Economic Evaluation and Added Value for Stakeholders of Switching From Rituximab Intravenous Injection to Rituximab Subcutaneous Injection In France

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2418
https://www.valueinhealthjournal.com/article/S1098-3015(15)04494-0/fulltext
Title : Economic Evaluation and Added Value for Stakeholders of Switching From Rituximab Intravenous Injection to Rituximab Subcutaneous Injection In France
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04494-0&doi=10.1016/j.jval.2015.09.2418
First page : A664
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1829
Categories :
Tags :
Regions :
ViH Article Tags :